XML 75 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Stockholders' (Deficit) Equity (unaudited) - USD ($)
Common Stock [Member]
Preferred Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2022 $ 2,900 $ 281,193,260 $ (795,840) $ (272,824,772) $ 7,575,548
Beginning balance, Shares at Dec. 31, 2022 289,992        
Issuance of RSUs $ 12 (12)
Issuance of RSUs (in Shares) 1,163          
Stock compensation expense 211,122 211,122
Offering of common stock and warrants, net of issuance costs $ 2,586 6,971,464 6,974,050
Offering of common stock and warrants, net of issuance costs (in Shares) 258,621          
Share cancellation $ (2) 2
Share cancellation, Shares (220)          
Foreign currency translation 153,067 153,067
Net income (As Restated) (5,736,603) (5,736,603)
Balances at March 31, 2024 (As Restated) at Mar. 31, 2023 $ 5,496 288,375,836 (642,773) (278,561,375) 9,177,184
Ending balance, Shares at Mar. 31, 2023 549,556        
Beginning balance, value at Dec. 31, 2023 $ 12,827 $ 2,500 293,991,529 (75,138) (305,493,302) (11,561,584)
Beginning balance, Shares at Dec. 31, 2023 1,282,686 250        
Issuance of RSUs $ 210 (210)
Issuance of RSUs (in Shares) 21,053          
Stock compensation expense 188,237 188,237
Offering of preferred stock $ 2,000 198,000 200,000
Offering of preferred stock, shares   200,000        
Reclassification of preferred stock par value to additional paid-in capital (out of period adjustment; see Note 3) $ (2,498) 2,498
Elimination of translation adjustments of previously dissolved subsidiaries (out of period adjustment; see Note 3) 75,138 75,138
Net income (As Restated) 287,967 287,967
Balances at March 31, 2024 (As Restated) at Mar. 31, 2024 $ 13,037 $ 2,002 $ 294,380,054 $ (305,205,335) $ (10,810,242)
Ending balance, Shares at Mar. 31, 2024 1,303,739 200,250